156 related articles for article (PubMed ID: 10073602)
1. Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1.
Moulin B; Deret S; Mariette X; Kourilsky O; Imai H; Dupouet L; Marcellin L; Kolb I; Aucouturier P; Brouet JC; Ronco PM; Mougenot B
J Am Soc Nephrol; 1999 Mar; 10(3):519-28. PubMed ID: 10073602
[TBL] [Abstract][Full Text] [Related]
2. Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin alpha heavy chain deposition.
Cheng IK; Ho SK; Chan DT; Ng WK; Chan KW
Am J Kidney Dis; 1996 Aug; 28(2):283-8. PubMed ID: 8768927
[TBL] [Abstract][Full Text] [Related]
3. Gamma-heavy chain deposition disease showing nodular glomerulosclerosis.
Yasuda T; Fujita K; Imai H; Morita K; Nakamoto Y; Miura AB
Clin Nephrol; 1995 Dec; 44(6):394-9. PubMed ID: 8719552
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal heavy chain (immunoglobulin G3) deposition disease: report of a case.
Herzenberg AM; Lien J; Magil AB
Am J Kidney Dis; 1996 Jul; 28(1):128-31. PubMed ID: 8712207
[TBL] [Abstract][Full Text] [Related]
5. A case of renal γ2 heavy-chain deposition disease accompanied by rapid progressive renal failure.
Chen GT; Liao XH; Yan RY; Li Y; Zhang L
Ir J Med Sci; 2014 Jun; 183(2):319-21. PubMed ID: 23963539
[TBL] [Abstract][Full Text] [Related]
6. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
[TBL] [Abstract][Full Text] [Related]
7. Nodular glomerulosclerosis secondary to mu heavy chain deposits.
Liapis H; Papadakis I; Nakopoulou L
Hum Pathol; 2000 Jan; 31(1):122-5. PubMed ID: 10665924
[TBL] [Abstract][Full Text] [Related]
8. Heavy Chain Deposition Disease: Clinicopathologic Characteristics of a Chinese Case Series.
Zhang Y; Li X; Liang D; Xu F; Liang S; Zhu X; Zheng N; Huang X; Liu Z; Zeng C
Am J Kidney Dis; 2020 May; 75(5):736-743. PubMed ID: 31699519
[TBL] [Abstract][Full Text] [Related]
9. A case of γ1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy.
Oe Y; Nakaya I; Yahata M; Sakuma T; Sato H; Soma J
Intern Med; 2010; 49(14):1411-5. PubMed ID: 20647658
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin gamma3-heavy-chain deposition disease: report of a case and relationship with hypocomplementemia.
Soma J; Sato K; Sakuma T; Saito H; Sato H; Sato T; Abbas A; Aucouturier P
Am J Kidney Dis; 2004 Jan; 43(1):E10-6. PubMed ID: 14712467
[TBL] [Abstract][Full Text] [Related]
11. Heavy chain deposition disease: recurrence in a renal transplant and report of IgG(2) subtype.
Herzenberg AM; Kiaii M; Magil AB
Am J Kidney Dis; 2000 May; 35(5):E25. PubMed ID: 10793054
[TBL] [Abstract][Full Text] [Related]
12. A unique case of γ-heavy chain deposition disease characterized by concomitant deposition of γ2 and γ4 subclasses.
Yin G; Wu Y; Zeng CH; Chen HP; Liu ZH
Intern Med; 2014; 53(22):2615-8. PubMed ID: 25400185
[TBL] [Abstract][Full Text] [Related]
13. Long-term renal survival of γ3-heavy chain deposition disease: a case report.
Katsuno T; Mizuno S; Mabuchi M; Tsuboi N; Komatsuda A; Maruyama S
BMC Nephrol; 2017 Jul; 18(1):239. PubMed ID: 28716013
[TBL] [Abstract][Full Text] [Related]
14. Gamma 1-heavy chain deposition disease accompanied by IgG kappa in serum, urine, and bone marrow.
Kaneko K; Seta K; Soma J; Kuwahara T; Koizumi M; Kikuchi Y; Sugawara A; Yahata K
CEN Case Rep; 2014 May; 3(1):44-48. PubMed ID: 28509245
[TBL] [Abstract][Full Text] [Related]
15. Articular, monoclonal gamma3 heavy-chain deposition disease: characterization of a partially deleted heavy-chain gene and its protein product synthesized in vivo and in vitro.
Thompson KM; Sletten K; Brandtzaeg P; Källberg E; Wien TN; Husby G
Arthritis Rheum; 2003 Nov; 48(11):3266-71. PubMed ID: 14613292
[TBL] [Abstract][Full Text] [Related]
16. A mouse model recapitulating human monoclonal heavy chain deposition disease evidences the relevance of proteasome inhibitor therapy.
Bonaud A; Bender S; Touchard G; Lacombe C; Srour N; Delpy L; Oblet C; Druilhe A; Quellard N; Javaugue V; Cogné M; Bridoux F; Sirac C
Blood; 2015 Aug; 126(6):757-65. PubMed ID: 26113545
[TBL] [Abstract][Full Text] [Related]
17. Heavy chain deposition disease: the disease spectrum.
Kambham N; Markowitz GS; Appel GB; Kleiner MJ; Aucouturier P; D'agati VD
Am J Kidney Dis; 1999 May; 33(5):954-62. PubMed ID: 10213655
[TBL] [Abstract][Full Text] [Related]
18. Pseudo-gamma heavy chain (IgG4 lambda) deposition disease.
Tubbs RR; Berkley V; Valenzuela R; McMahon JT; Gephardt GN; Fishleder AJ; Nally JV; Pohl MA; Bukowski RM; Lichtin AE
Mod Pathol; 1992 Mar; 5(2):185-90. PubMed ID: 1574496
[TBL] [Abstract][Full Text] [Related]
19. [Heavy chain deposition disease: report of a case and review of the literature].
Imai H
Rinsho Byori; 2001 Jul; 49(7):695-8. PubMed ID: 11519134
[TBL] [Abstract][Full Text] [Related]
20. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.
Nasr SH; Markowitz GS; Stokes MB; Seshan SV; Valderrama E; Appel GB; Aucouturier P; D'Agati VD
Kidney Int; 2004 Jan; 65(1):85-96. PubMed ID: 14675039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
